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The use of Selenomethionine (SeMet) incorporated protein crystals for single or multi-
wavelength anomalous diffraction (SAD or MAD) to facilitate phasing has become 
almost synonymous with modern X-ray crystallography. The anomalous signals from 
SeMets can be used for phasing as well as sequence markers for subsequent model 
building. The production of large quantities of SeMet incorporated recombinant proteins 
is relatively straightforward when expressed in E. coli. In contrast, production of SeMet 
substituted recombinant proteins expressed in the insect cells is not as robust due to 
the toxicity of SeMet in eukaryotic systems. Previous protocols for SeMet-incorporation 
in the insect cells are laborious, and more suited for secreted proteins. In addition, these 
protocols have generally not addressed the SeMet toxicity issue, and typically result in 
low recovery of the labeled proteins. Here we report that SeMet toxicity can be 
circumvented by fully infecting insect cells with baculovirus. Quantitatively controlling 
infection levels using our Titer Estimation of Quality Control (TEQC) method allows for 
incorporation of substantial amounts of SeMet, resulting in an efficient and optimal 
production of labeled recombinant protein complexes. With the method described here, 
we were able to consistently reach incorporation levels of about 75% and protein yield 
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of 60-90% compared to native protein expression.  
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Introduction 
Single or multi-wavelength anomalous diffraction (SAD or MAD) phasing by 
utilizing Seleno-methionine (SeMet) labeled proteins or protein complexes is almost 
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synonymous with modern X-ray crystallography.1,2 This method has drastically reduced 
the need for preparation of heavy atom derivatives, which is one of the most time-
consuming steps in X-ray crystallography. The anomalous signal from SeMet can be 
used for phasing as well as for identifying methionine positions within the electron 
density map, thereby aiding model building in low resolution maps.3,4  
 Production of SeMet-labeled proteins in E. coli for X-ray crystallography is well 
established and robust.1  Protocols exist for yeast Saccharomyces cerevisiae,3 yeast 
Pichia pastoris,5 the insect cells6,7 as well as mammalian cells.8 While SeMet 
incorporation routinely achieves 100% for proteins expressed in E. coli, expression in 
eukaryotic cells is much more variable, with SeMet incorporation ranging from 50% to 
90%, depending on the host cells and proteins being produced.5,7-10  
The baculovirus expression system (BEVS) is an excellent tool for expressing 
recombinant proteins in insect cells. It is considered an attractive option for proteins as 
well as protein complexes and has been widely used for structural and functional 
studies.11-13 For production of SeMet-labelled proteins using the BEVS in the insect 
cells, the protocol by Bellizzi et al. has been widely cited.6 However, as pointed out by 
Cronin et al.,7 this protocol is suited for secreted proteins such as glycosylated 
lysosomal hydrolase,6 and CD40,14 and is not necessarily applicable for intracellular 
expression. Moreover, this protocol requires several medium-exchanges and dialyzed 
FBS added to the methionine-free medium in order to maintain cell viability during 
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methionine depletion. Since higher labor demand (more personnel cost) as well as 
requirement of additional reagents such as FBS will add to the overall cost of operation, 
this protocol could potentially become costly. To overcome some of these limitations, a 
protocol designed for secreted as well as intracellularly expressed proteins was 
published.7 However, this protocol still retains the cumbersome medium exchange in 
the midst of the operation, and yields were drastically reduced: 18%-45% compared to 
the native protein. Low yield of SeMet-labeled proteins is a serious problem as it limits 
crystallization conditions for screening, optimization, and production of crystals, and low 
incorporation rates reduce the available anomalous signal. Moreover, additional 
preparations are required to achieve desired protein yield leading to increased costs as 
well.  
 In our work on the yeast Mediator Head module, which is an essential sub-
complex of the Mediator complex, and a key component of transcription regulation in 
eukaryotes,15 we encountered a similar problem. The Mediator Head Module is 
composed of seven subunits with a total molecular mass of 223 kDa. We generated the 
recombinant complex in the insect cells using the MultiBac baculovirus expression 
vector system for structural and functional studies.4,16 We wanted to use the SeMet-
labeled Mediator Head module for phasing as well as for model building purposes. 
Using a protocol similar to that from Cronin et al.7 or the protocol provided by the 
manufacturer (Expression Systems, Inc), we achieved only 10% or less recovery of the 
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Mediator Head module compared to the native expression level. A substantial reduction 
of the SeMet-labeled protein yield could likely be attributed to SeMet toxicity. Although 
this toxicity is wildly recognized in the field, there is no detailed experimental data 
available as to toxic dosages of SeMet to the insect cells. Chen and Bahl reported that 
100 μg/ml of SeMet was toxic but they did not present dose-dependent toxicity data, or 
experimental details.17 Further, there has been no investigation undertaken of potential 
ways to bypass or reduce the detrimental effects of SeMet on the insect cells, as it had 
been published for yeast S. cerevisiae.10,18 
Considering the limitations and intricacy of the current SeMet-labeling methods in 
the insect cells,6,7,17 we decided to analyze critical aspects of SeMet incorporation in the 
insect cells in order to improve quality and quantity of SeMet-labeled proteins. We 
report here that SeMet is indeed toxic to the insect cells, but such toxicity can be 
circumvented by high baculovirus infection levels. We developed a simple, quantitative, 
and easy-to-use protocol for the generation of SeMet-labeled proteins or protein 
complexes in the insect cells.  
Results 
Sf9 and Hi5 insect cells are resilient to methionine depletion 
We started off investigating the effect of methionine depletion on cell viability in 
Sf9 and Hi5 cells. We wanted to test if supplementing dialyzed FBS for cell 
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maintenance under met-depleted conditions6,17 is necessary. Both cell lines were 
maintained in serum-free ESF921 medium (Expression Systems, Inc). Cells, Hi5 or SF9, 
were spun down and resuspended in either the Met-containing ESF921 medium 
(control) or Met-free ESF921 medium in a 50 ml culture with a cell density of 0.5 x 106
(Hi5) or 0.6 x 106 (Sf9) cells/ml. Cell viability (% of live cells) and cell density of each 
culture was monitored every 24 hours for a total of 4 days (Fig. 1). Although growth of 
Hi5 cells in the methionine-free medium began to be compromised on day 3, Sf9 cells 
remained the same as the control culture during the 4-day incubation period. More 
importantly, there is essentially no difference in cell viability with or without methionine 
in both cell lines [Fig. 1(A), 1(C)], suggesting strongly that both insect cell lines are 
resilient to methionine depletion for an extended period of time: Sf9 for at least 96 
hours, and Hi5 for 48 hours. Therefore, we concluded that (i) addition of dialyzed FBS 
during methionine depletion is unnecessary, and that (ii) methionine depletion can be 
sustained for at least 48 hours for Hi5 cells, and 96 hours for Sf9 cells.  
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SeMet is toxic to the insect cells 
Next, we examined SeMet toxicity in the insect cells in the presence or absence 
of Met by monitoring cell viability as well as overall cell growth. Sf9 or Hi5 cells were 
passaged with fresh ESF921 medium (Met+, control) or Met-free ESF921 medium 
(Expression System, Inc) to a cell density of 0.5 x 106 cells/ml in a 50 ml culture. 
Various amounts of SeMet, ranging from 0 mg/L to 200 mg/L, were added to both sets 
of cultures (Met+ or Met-). Cell viability (% of live cells) and cell density (total cell 
density) of each culture was monitored every 24 hours for 4 days (Fig. 2). In the 
presence of Met, viability and growth of Sf9 cells were only slightly affected by SeMet at 
a concentration of 20-80 mg/L; at 120-200 mg/L, cell viability began to decrease [Fig. 
2(A), 2(B)]. Hi5 cells are more susceptible to the presence of SeMet, and their viability is 
dependent on the SeMet concentration in the medium [Fig. 2(E), 2(F)]. In the Met-free 
medium, the toxic effect of SeMet appears to manifest itself more prominently such that 
the cell viability drops to 40% in Sf9 cells [Fig. 2(C)] or 18% in Hi5 cells [Fig. 2(G)] at 80 
mg/L SeMet. At 80 mg/L or higher, cell viability of both cells declined to ~20% [Fig. 2(C), 
2(G)], and cell growth of both cell lines was severely compromised [Fig. 2(D), 2(H)]. 
These data clearly suggest that SeMet has detrimental effects on cell viability and cell 
growth per se, and impacts cell culture growth significantly at concentrations of 80 mg/L 
or higher in Met-free medium. Based on the data presented here, the amounts of SeMet 
used in several publications6,7,14,17,19,20 clearly fall in the toxic range.  
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SeMet toxicity can be circumvented by baculovirus infection 
Having established that the insect cells are resilient to Met depletion for an 
extended period of time (Fig. 1), and that SeMet is indeed toxic to the insect cells at 
concentrations at 80 mg/L or higher under Met depleted conditions (Fig. 2), we 
investigated the relationship between SeMet incorporation, and the yield of the SeMet-
labeled Mediator Head module. For this purpose, we set up cultures of Hi5 cells infected 
with the Mediator Head module virus at an estimated multiplicity of infection (eMOI) of 
3.7, which gave consistently high yield in a native expression as we reported previously 
21, and titrated increasing amounts of SeMet into the cultures (Fig. 3). In this 
experiment, Hi5 cells were chosen because the Mediator Head module expressed 
significantly better in Hi5 cells than Sf9 cells.21 The overall experimental scheme is 
described in Figure 3(A). For ease of implementation, our labeling protocol was divided 
into 24 hours (one day) increments. On Day 0, Hi5 cells grown in log phase were spun 
down and resuspended in Met-free medium. Cultures were incubated for 24 hours to 
deplete Met, and after adjusting for cell density, the baculovirus expressing the Mediator 
Head module was added to each culture (Day 1) with an eMOI=3.7 21. On Day 2, 0 
(control) to 200 mg/L SeMet was added to each culture and 100mg/L Met was added to 
the native control culture. Cell density and viability were monitored every 24 hours over 
a 4-day period (Day 1-5). To our surprise, we saw no significant SeMet toxicity as 
assessed by cell density and viability over the measured time period [Fig. 3(B), 3(C)]: 
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Cell viability at 200 mg/L SeMet (52%) was similar to that of the native control with 100 
mg/L Met (53%) added [Fig. 3(B)]. Our previous work showed that Hi5 cells were fully 
infected with an eMOI=3.7.21 Thus, we hypothesize that high baculovirus infection levels 
could circumvent the SeMet toxicity in the insect cells.   
Cell viability and recovery of the SeMet-labeled Mediator Head module in the 
presence of a toxic amount of SeMet depends on infectivity (or eMOI)  
If a high baculovirus infection level could evade the SeMet toxicity, thereby 
maintaining cell viability, it should lead to higher recovery of SeMet-labeled proteins or 
protein complexes. Therefore, we further hypothesized that optimal baculovirus infection 
is as critical for optimal SeMet-labeled protein yield as it is for cell viability in terms of 
evading SeMet toxicity: optimal baculovirus infection leads to optimal SeMet-labeled 
protein yield.  
To test this hypothesis, we set up a virus titration such that the infectivity of the 
insect cells at the time of SeMet addition varied from low (22%) to high (~100% infected 
cells) in order to see if there is a correlation among infectivity, cell viability, and SeMet-
labeled protein yield in the presence of a toxic amount of SeMet. We previously 
developed the Titer Estimation of Quality Control (TEQC) method, which enables us to 
quantitatively control virus infection levels.21 Using our TEQC method, the titer value of 
our virus stock was estimated and cultures with a total of five different estimated initial 
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infectivities (infectivity 24 hours after addition of virus: eI24), ranging from 22%, 39%, 
63%, 86% to 98%, were set up. These initial infectivities correspond to estimates of 
multiplicity of infection (eMOIs) of 0.25 (22%), 0.5 (39%), 1.0 (63%), 2.0 (86%), and 4.0 
(98%), respectively. It should be noted that the mathematical relationship between an 
initial infectivity (I24) and MOI is non-linear: I24=1-e-MOI 21. The corresponding eMOI, 
instead of infectivities, were used for the experiments in Figure 4, since this 
experimental condition is more convenient to set up. For instance, an eMOI=2 implies 
twice as much virus volume was added than for eMOI=1. As for controls, native 
expressions were set up in parallel using identical eMOI conditions. As shown 
previously, Hi5 cells are better suited for expression of the Mediator Head module,21 
and thus, Hi5 cells were used for this experiment. Following the same experimental 
scheme [Fig. 3(A)], after Met depletion and adjustment of cell density the baculovirus 
was added to each culture with eMOI from 0.25 to 4.0 (Day 1). On Day 2 (24 hours after 
virus addition), SeMet was added at a final concentration of 160 mg/L, which was 
shown to be highly toxic in the absence of infection [Fig. 2(G)], or Met was added at a 
final concentration of 100 mg/L as a native expression. Cell viability of each culture was 
monitored every 24 hours for a 4-day period (Day 1-5) [native: Fig. 4(A); SeMet: Fig. 
4(B)]. On Day 5, cells were harvested, and the Mediator Head module was purified and 
quantified. Comparison in cell viability between a native vs. SeMet containing 
expressions on Day 5 is displayed in Figure 4(C).  
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In the native expressions, cell viability went down to ~60% at eMOI greater than 
2.0, which corresponded to the infectivity >86% on Day 5, while at low eMOIs (0.25, 0.5, 
or 1.0) or infectivity = 22%, 39%, or 63%, cell viability was in a range of 72-85% [Fig. 
4(A), 4(C)]. In the presence of SeMet (160 mg/L), cell viability was severely 
compromised at low eMOIs (0.25, or 0.5) or infectivity < 39% [Fig. 4(B), 4(C)]. We 
speculate that this is due to a large percentage of cells being uninfected at the time of 
SeMet addition, and thus, far more prone to SeMet toxicity than infected cells. In 
contrast, at the higher eMOI range (2 or greater, or infectivity > 86%), cell viability went 
down to 57% [Fig. 4(B), 4(C)], which was almost the same cell viability of the culture 
infected with eMOI=4.0 (infectivity 98% or higher) of the native expression (61%) [Fig. 
4(C)], indicating that cell viability at higher eMOI was not significantly affected under 
SeMet-labeling conditions: fully infected insect cells are far more resilient to SeMet 
toxicity than the uninfected.  
Next, we looked into virus infectivity (or eMOI) and protein complex recovery. 
Protein yields were compared with those from native expression [Fig. 4(D)]. As for the 
native expression, protein complex yield appeared to reach a plateau at eMOI=1.0 or 
higher [Fig. 4(D), 4(E)]. In contrast, in the presence of SeMet, highly infected cells 
(eMOI = 4) produced more protein complex than lower eMOI [Fig. 4(D), 4(E)]. For 
example, the condition of eMOI=4 yielded 71% of the protein complex compared to that 
of the native expression, whereas only 27% of the native set up was recovered from 
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cells infected with a low eMOI of 0.5. There is no significant difference in cell viability 
between cultures set up with eMOI =2.0, and 4.0. However, the protein complex yield 
recovered from the culture with eMOI=4.0 was ~34% better than that eMOI=2.0.  
Taken all together, the data strongly suggests that a recovery of SeMet-labeled 
protein complex correlates with the infectivity (or eMOI) [Fig. 4(C), 4(D)]: generating a 
condition of full infection (eMOI ≥ 4.0) at the time of SeMet addition should lead to 
optimal recovery of SeMet-labeled protein complexes.  
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Optimal SeMet concentrations for SeMet labeling of the Mediator Head module 
expressed in Hi5 or Sf9 insect cells 
After establishing the optimal conditions for evading SeMet toxicity without 
compromising recombinant protein recovery– adding the baculovirus with eMOI ≥ 4.0 – 
we investigated whether the higher tolerance for SeMet affects its incorporation into the 
recombinant protein complex. Ultimately, it is desirable to obtain high yield as well as a 
high SeMet incorporation. To study the effects of various SeMet concentrations on their 
incorporation into the Mediator Head module, Hi5 insect cells were cultured in Met-free 
medium followed by addition of the baculovirus expressing the Mediator Head module 
with an eMOI of 4 in order to fully infect cells. SeMet was added in concentrations 
ranging from 20 to 200 mg/L. As a control, a native expression test was set up in 
parallel with Met added at a final concentration of 100 mg/L. For each condition, the 
protein complex was purified and the yield was determined. The percentage of SeMet 
incorporation was measured by amino acid analysis (AAA). Consistent with the 
previously reported results,7 high concentration of SeMet resulted in higher 
incorporation of SeMet [Fig. 5(A)]. The SeMet incorporation gradually increased and 
peaked at 160 mg/L with 75% incorporation [Fig. 5(A)]. Consistent with the data in 
Figure 4C, the recovery of the protein complex was comparable to native levels up to a 
SeMet concentration of 160 mg/L [Fig. 5(B)]. The peak recovery of the complex at 160 
mg/L SeMet is about 75% of that of native protein yield. No increase in incorporation 
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level was observed at 200 mg/L SeMet [Fig. 5(A)], but Mediator Head Module recovery 
was severely compromised at this concentration [Fig. 5(B)]. We concluded that for Hi5 
cells, the maximum concentration of SeMet is 160 mg/L without overly compromising 
the recovery of the protein complex and achieve 75% SeMet incorporation.   
 Next, we conducted the same experiment in order to find out the optimal SeMet 
concentration for expression of the Mediator Head module in Sf9 cells. Since Sf9 cells 
appear to accommodate more SeMet than Hi5 cells (Fig. 2),7 we started the SeMet 
titration from 160 mg/L all the way up to 280 mg/L [Fig. 5(C), 5(D)]. In this range, 160-
280 mg/L, SeMet incorporation reached 75% at 200 mg/L and there is no increase at 
higher concentration, suggesting that 75% is the upper limit for SeMet incorporation, 
consistent with the previous report.7 The recovery of SeMet labeled Mediator Head 
module decreased as the concentration of SeMet increases [Fig. 5(D)]. Considering 
SeMet incorporation rate as well as the complex recovery rate, we concluded that for 
Sf9 cells, the optimal concentration of SeMet is 200 mg/L without overly compromising 
the recovery of the protein complex and achieving 75% SeMet incorporation.   
  
Application of our SeMet labeling method to multi-protein complexes involved in 
RNA polymerase II transcription  
We further tested a generality of our labeling method by applying it to three other 
multi-protein complexes involved in RNA polymerase II transcription:22,23 human Taf8-
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Taf10 heterodimer with a molecular mass of 81kDa, yeast Mediator Middle module 
composed of seven subunits with a molecular mass of 190 kDa, and yeast TFIIF 
composed of three subunits with a molecular mass of 156 kDa, respectively. In our 
previous studies, the expression levels of human Taf8-Taf10, and yeast Mediator 
Middle module were fairly similar from low eMOI (0.5) to high eMOI (4.0) under native 
expression conditions. In fact, the optimal expression for the Mediator Middle module 
occurred with an eMOI= 0.5.21 Yeast TFIIF was chosen to test the SeMet-labelling in 
Sf9 cells because it is one of only a few protein complexes we tested so far that 
expresses better in Sf9 cells than Hi5 cells.21 Following our protocol (supplemental 
protocol), Hi5 cells or Sf9 cells were cultured in Met-free medium for 24 hours followed 
by addition of the baculoviruses expressing each of these complexes with eMOIs 
ranging from 0.5 to 4.0. SeMet was added to each culture at a final concentration of 160 
mg/L SeMet for Hi5 cells, and 200 mg/L for Sf9 cells 24 hours after infection. In parallel, 
native expressions using the same eMOI were set up as controls. The protein 
complexes were purified, yields of protein complexes were determined, and the extents 
of SeMet incorporation were measured (Fig. 6).   
Consistent with our previous observation, the protein complex yields are fairly 
similar across different eMOI values for all three native complexes.21 Interestingly, the 
optimal eMOIs for all three complexes are at lower levels compared to the Mediator 
Head Module (Taf8-Taf10: 0.5; Mediator Middle module: 0.5; TFIIF: 1.0). However, in 
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the presence of SeMet the complex yields expressed at a low eMOI were substantially 
reduced and the highest recovery was achieved with an eMOI of 4.0 (> 98% infectivity), 
which is in line with our observations for the Mediator Head module. Compared to the 
native expression, yields of the complexes are ranging from 56% for TFIIF to almost 
70% for Taf8-Taf10 and Mediator Middle module with an eMOI of 4.0 and SeMet 
incorporation of these three complexes reached 68% to 78%. Taken together, these 
results clearly indicate that our labeling method is applicable to multiple systems. Since 
implementation of our TEQC protocol is key for this SeMet-labeling method, we name it 
SeM-TEQC method. 
 
Validation of our 24h-increment labeling protocol  
One element of our experimental set up is a 24-hour infection period for the 
baculovirus prior to the addition of SeMet. If the Mediator Head module is expressed in 
this period, it would result in a production of non-SeMet-labeled protein complex, which 
may contribute to lowering the overall SeMet incorporation rate and may explain the 
maximal labeling of 75% we observed. Cronin et al.7 indicated that addition of SeMet 
within the first 16 hours following viral infection is critical for reducing a production of 
non-SeMet-labeled protein – a key point in their report. Therefore, we decided to 
examine how much of the protein complex is expressed in the first 24 hours and 
thereafter. Following the experiment scheme illustrated in Figure 3(A), we monitored 
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expression of the Mediator Head module throughout the incubation period (Day 1-5) by 
western blotting using antibodies against 10His-Med17 (Δ1-108), Med18 (Δ109-140), 
and Med11 subunits of the Mediator Head module. In this experiment, every 24 hours, a 
small aliquot from the culture was taken at 24 hours intervals, and expressions of the 
three representative subunits mentioned above were probed by western blotting. As for 
a control, we set up a native expression of the Mediator Head module to which Met was 
added on Day 2 instead of SeMet. In the first 24 hours after addition of the virus, there 
was no detectable expression of any one of the three probed subunits in either the 
SeMet or native expression cultures (Fig. 7). These data argue against the idea of a 
substantial production of non-SeMet-labeled protein complex between Day 1 and 2, 
further substantiating our 24h-increment labeling protocol.  
Use of SeMet-labeled Mediator Head module for X-ray crystallography 
The SeMet-labeled Mediator Head module was crystallized under similar 
conditions as the native Mediator Head module. The SeMet-labeled crystals were 
isomophorous with native crystals with a similar size. SeMet-containing crystals 
diffracted to 4.3 Å, and so did a representative native crystal. A scan of X-ray–induced 
fluorescence on the SeMet crystals demonstrated an absorption peak at 0.97948 A° 
(12,662 eV), consistent with the presence of SeMet. Diffraction data were collected at 
this wavelength, and processed with HKL200024 as described previously.4 The initial 
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phases were determined by SIRAS using the Ta6Br14 derivative or SAD by using the 
K3Ir(NO3)6 derivative. The phasing results were quite similar for both derivatives. The 
initial phases were extended by density modification by program PARROT, using SeMet 
datasets descried previously.4 On the last step of the phasing, 98 SeMet peaks of a 
possible 141 sites (~70%) in the unit cell were identified manually, and were used to 
calculate the experimental phases by the program PHASER.25 The final experimentally 
phased map and the SeMet peaks were used for model building of the Mediator Head 
module as described previously.4   
To evaluate anomalous differential Fourier map peak positions with SeMet 
positions, peaks were researched by CCP4 program FFT from anomalous difference 
Fourier peak height from more than 3.5σ to 8σ, and summarized in Table 1. A total of 
97 SeMet peaks were higher than 4.0σ in 20–6 A°, suggesting high quality of 
anomalous signals from Selenium in the crystals. It should be noted that CCP4 program 
FFT26 identified 97 SeMet peaks within a unit cell while 98 were identified manually.  
To further validate Selenium peaks, we compared the known positions of 
methionine residues in the high-resolution structure of Med18-Med20, sub-complex of 
the Mediator Head module previously determined by X-ray analysis4 with the Selenium 
anomalous peaks by placing Med18-Med20 structure onto the 4.3 Å Mediator Head 
module map. Selenium anomalous difference Fourier map peak heights of Med18 and 
Med20 were summarized in Table 2. Peaks ranging from 3.0 σ to 9.6 σ were observed 
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for 17 of possible 27 methionine sites for Med18, and 5 of possible 9 methionine sites 
for Med20 were observed: 22 of a possible 36 sites (61%) (Table 2) –the methionine 
residues at N-termini of both subunits were not included. Anomalous difference Fourier 
map peaks calculated from 20-6 Å at contoured at 3 σ, nicely correlate with the location 
of known methionine sites in all 3 molecules found in the asymmetric unit [Fig. 8(A-C)].  
Discussion 
In this work, we developed a simple and robust protocol termed SeM-TEQC 
method for productions of SeMet-labeled protein complexes in the insect cells by 
addressing the issues related to (i) effect of Met depletion on the cells, (ii) timing of 
addition of SeMet, and most importantly, (iii) SeMet toxicity toward the insect cells. Our 
first finding was that the insect cells tolerate Met depletion for an extended period of 
time under otherwise normal growth conditions (Fig. 1), making medium exchanges with 
dialyzed FBS, or any other supplemental reagents during methionine starvation as 
reported previously6,17 unnecessary. Second, based on our analysis, no detectable 
protein expression was observed 24 hours following the virus infection (Fig. 7), 
eliminating the need for SeMet addition 16 hours after viral infection7 and permitting a 
more feasible 24-hour schedule. Finally, and most importantly, we addressed the issue 
of the SeMet toxicity in the insect cells. This work outlines cell line dependent toxicity 
thresholds and establishes that the inherent SeMet toxicity can be evaded by optimizing 
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baculovirus infection levels. Our previously developed TEQC method proved as an 
essential tool to limit SeMet toxicity as such it allows us to quantitatively control virus 
infection levels in a convenient and easy manner, and is crucial for optimal SeMet 
incorporation. In brief, to achieve full baculovirus infection, the eMOI needs to be 4.0 or 
higher, which corresponds to ~98% infectivity.21 In retrospect, the condition used by 
Chen and Bahl corresponds to an MOI of 5-10 for SeMet-labeleling of human 
choriogonadotropin (hCG) in the insect cells, which turns out to be in the optimal range 
to evade SeMet toxicity, even though the authors failed to provide the reasoning to their 
MOI choice.17 Similarly, a high MOI was used in the works of Carfi et al.27 and Bellizzi et 
al.6 without any explanation as to why. On the contrary, Cronin et al. used a baculovirus 
MOI of 1 for infection, which is, according to our results, less optimal to evade SeMet 
toxicity and might explain the low recovery of SeMet-labeled proteins they 
encountered.7  
Possible mechanism of SeMet toxicity 
Mechanism of SeMet toxicity toward eukaryotic cells has been studied mostly 
using the yeast Saccharomyces cerevisiae.10,18 As these studies indicated, SeMet 
toxicity appears to come from two different mechanisms: SeMet likely generates 
reactive species, resulting in DNA damage,28 consistent with the observation that SeMet 
could effectively inhibit the insect cell growth.17 Alternatively, SeMet toxicity results from 
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its metabolites, and a random incorporation of which promotes protein aggregation – 
SeMet causes proteotoxic stress resulting in cell death.29 How does baculovirus 
infection reduce SeMet toxicity? As reported, baculovirus infection results in cell cycle 
and DNA replication arrest.30,31 Once infected, the insect cells are no longer able to 
divide. As a result, the effect of SeMet-induced DNA damage could be neutralized, 
thereby maintaining overall cell viability as we observed (Fig. 3, 4).   
Considering the mechanism of SeMet toxicity being attributed to SeMet 
metabolites, we reasoned that SeMet toxicity could be minimized by reducing the 
amount of toxic SeMet metabolites (e.g. Selenocysteine) through impairing conversion 
of Se-adenosylselenomethionine (SeAM) to Se-adenosylselenohomocysteine (SeAH).32 
In fact, this strategy worked well in the yeast S. cerevisiae by knocking out genes 
(SAM1, SAM2, or CYS3) encoding enzymes S-adenosylmethionine synthetase, or 
Cystathionine gamma-lyase in the pathway that produces toxic SeMet metabolites.10,18 
Accordingly, we attempted to apply a similar idea to disrupt conversion of SeMet to 
SeAM by addition of SAM to the medium, which we hoped competes with SeAM as a 
substrate for methyltransferases, thereby minimizing the synthesis of SeMet 
metabolites. However, addition of SAM to the growth medium did not reduce overall 
SeMet toxicity (data not shown). Thus, supplementing SAM to the insect cell culture 
may not effectively disrupt the metabolic pathway that produces SeMet metabolites as 
shown in yeast.10,18 Thus, the main SeMet toxic effect may result from SeMet-induced 
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DNA damage and not via toxic SeMet metabolites. Alternately, it might be simply that a 
complete viral infection is forcing all excess SeMet toward incorporation into the 
recombinant protein, avoiding toxic cellular effects seen for uninfected cells.  
Regardless, deciphering the exact mechanisms is beyond the scope of this work and 
will have to be addressed at a later time.   
  
Generality of the SeM-TEQC method 
The Mediator Head module was used as a model protein complex to develop the 
SeM-TEQC method with subunits composition ranging from 15 kDa to 77 kDa. 
Moreover, we have shown applicability of our method by expanding our protocol to label 
human Taf8-Taf10 heterodimer with a molecular mass of 81 kDa, yeast Mediator Middle 
composed of seven subunits with a molecular mass of 190 kDa, and yeast TFIIF 
composed of three subunits with a molecular mass of 156 kDa. There was no significant 
difference among these complexes in terms of SeMet incorporation level, and protein 
yield compared to their corresponding native expressions, supporting the generality of 
our method. Having focused primarily on expression and SeMet incorporation of multi-
protein complex, application of our method on single-subunits has been successfully 
achieved and led to the structure determination of the tight junction protein Claudin by 
SeMet SAD phasing,33 again proving the versatility of the SeM-TEQC method.  
As Cronin et al. pointed out,7 the advantage of the existing methods for secreted 
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proteins, including engineered secrete expression,6,17 lies in its ability to remove 
unlabeled proteins by medium exchange during the procedure, thereby increasing 
overall SeMet incorporation. For example, Chen and Bahl reported17 that SeMet 
incorporation rate of human choriogonadotropin (hCG) reached 84%, which is better 
than what our SeM-TEQC method (~75%) achieved. However, the report by Bellizzi et 
al.6  - this publication that has been widely cited for SeMet protocol for BEVS in the 
insect cells - indicated that their SeMet incorporation rate was 76%, which is 
comparable to that of the SeM-TEQC method. However, our protocol was developed 
primarily for intracelluar multi-protein complexes. It has not been applied to secreted 
proteins yet.  It still remains to be seen how well SeM-TEQC method works for those. 
Based on our current results, we would expect it to work equally good if not better than 
the existing methods 
Conclusions 
Our discovery that SeMet toxicity can be circumvented by a high baculoviral 
infection led us to develop a simple and quantitative SeMet-labeling method termed 
SeM-TEQC. The overall scheme is illustrated in Figure 9. This method does not require 
laborious procedures (medium exchange during the procedure) or additional reagents 
(e.g. dialyzed FBS). Thus, this method is more cost effective compared to the exiting 
protocols. The protocol steps are carried out in 24 hours increments, making the 
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procedure practical and easy to implement. Our SeM-TEQC method enables an optimal 
production of SeMet-labeled proteins or protein complexes with SeMet incorporation 
levels to about 75% and protein yield of 60-90% compared to the native protein 
expression.   
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Materials and Methods 
Maintenance of the insect cells, recombinant baculovirus production, virus 
storage, and virus titer estimation 
 Cells are maintained as described.21 Generation of recombinant baculoviruses 
was described.21,34 Generation of frozen virus stocks was described.21,35 The titer 
estimates of the recombinant baculoviruses (eTiters) were determined by TEQC method 
as described.21   
 
Cell proliferation assay for methionine depleted conditions: 
 Healthy dividing Hi5 or Sf9 insect cells were centrifuged in a 50 ml conical tube 
and methionine-containing medium (ESF921) (Expression systems, Davis CA) was 
discarded. Cells were resuspended in Met-free ESF921 medium (delta series, 
methionine deficient) (Expression systems, Davis CA), or as a control, methionine-
containing medium (ESF921) to set up a 50 ml culture with a cell density of 0.5 x 106 
cells/ml for Hi5 cells or 0.6 x 106 cells/ml for Sf9 cells. Cell cultures were incubated on a 
shaker at 125 rpm at 27°C. Every 24 hours for up to 96 hours, the cell density as well as 
cell viability were measured with a TC20TM Automated Cell counter (Bio-Rad).  
 
Cell proliferation assay in presence of SeMet:  
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 Healthy dividing Hi5 or Sf9 insect cells were centrifuged in a 50 ml conical tube 
and methionine-containing medium (ESF921) was discarded. Cells were resuspended 
in methionine-free medium (ESF921), and as a control, methionine-containing medium 
to set up a total of 7 flasks of 50 ml cultures with the cell density of 0.5 x 106 cells/ml for 
Hi5 cells or 0.6 x 106 cells/ml for Sf9 cells. Sets of cultures in methionine-containing 
medium or in methionine-depleted medium were set up in parallel. SeMet was added to 
each culture at the concentration indicated in the figure legends. Cell cultures were 
incubated at 27°C while shaking at 125 rpm. Every 24 hours, the cell density and 
viability were measured with a TC20TM Automated Cell counter (Bio-Rad).  
 
Expressions of native and SeMet-labeled protein complexes 
 Expressions of native multi-protein complexes were performed in 200 ml cultures 
with 1.0 x 106 cells/ml of Hi5 cells or 1.5 x 106 cells/ml of Sf9. Cultures were infected 
with the recombinant baculoviruses at the indicated eMOI, which was calculated by our 
TEQC method.21 Each culture was incubated at 27°C for 96 hours. The expression of 
SeMet-labeled protein complexes is described in detail in the Supplemental protocol. 
Briefly, for medium exchange, Hi5 or Sf9 insect cells were centrifuged, methionine-
containing medium was discarded, and cells resuspended in 200 ml methionine-
depleted medium ESF921 to a cell density of 1.0 x 106 cells/ml for Hi5 cells or 1.5 x 106 
cells/ml for Sf9 cells. Cell cultures were incubated on a shaker at 125 rpm for 24 hours 
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at 27°C in order to deplete endogenous methionine. After 24 hours, cell density was 
adjusted to 1.0 x 106 cells/ml in 200 ml for Hi5 cells or 1.5 x 106 cells/ml for Sf9 with 
methionine-free medium. At this point, cells were infected with baculovirus at the 
various eMOI values indicated in the main text. After incubating for another 24 hours at 
27°C, SeMet was added to a final concentration of 20-200 mg/L and cells cultured for 
72 hours. Cells were harvested by centrifugation, cell pellets were frozen in liquid 
nitrogen, and stored at -80°C until use.  
Purification of protein complexes 
Purification procedures for the Mediator Head module, Taf8-Taf10, TFIIF, and 
Mediator middle module were described previously.21 
Determination of SeMet incorporation by amino acid analysis (AAA) 
The incorporation of SeMet was determined by amino acid analysis carried out at 
The University of California Davis proteomics core facility. The details of AAA are 
described in (http://msf.ucdavis.edu/amino-acid-analysis/). Briefly, since Met is 
destroyed during hydrolysis with 6 N HCl, Met was determined by converting it to the 
acid stable form, methionine sulfone, with oxidation using performic acid, prior to the 
standard acid hydrolysis.36 Quantity of each amino acid was measured by AAA.  Since 
valine (Val), leucine (Leu), and phenylalanine (Phe) are least affected by the oxidation 
process with performic acid, we used the average quantity of these three amino acids to 
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compare the Met ratio in native and SeMet-labeled proteins. The percentage of SeMet 
incorporation was calculated using the following equation:  
SeMet incorporation rate = 1 − [𝑀𝑒𝑡𝐴𝑣𝑒](𝑠𝑒)[𝑀𝑒𝑡
𝐴𝑣𝑒
](𝑛) , where Met (n): quantity of Met under a native 
expression; Ave (n): average quantity of Val, Leu, and Phe combined under a native 
expression; Met (se): quantity of Met under SeMet-labeling expression; Ave (se): 
average quantity of Val, Leu, and Phe combined under SeMet-labeling expression. The 
detailed description of how this equation was derived is described in Supplemental 
Materials. The ratio in quantity between Met and the average value of Val, Leu, and Phe 
under native as well as SeMet-labeling expression condition was first calculated 
followed by determining the incorporation rate using the equation described above.  
 
X-ray crystallography for the SeMet-labeled Mediator Head module  
  The SeMet-labeled Mediator Head module crystals were obtained by the hanging-
drop vapor-diffusion method as described previously.4 Diffraction data were collected at 
beamline 23ID at the Advanced Photon Source (APS) at Argonne National Laboratory. 
All diffraction data were processed with HKL2000. The structure was determined by 
selenomethionine (SeMet) single-wavelength anomalous dispersion (SAD) after a 
sufficient number (98) of SeMet sites had been identified by a combination of the initial 
phases from Ta6Br14 and Iridium derivatives, and partial model SAD phases as 
described previously.4 
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 Western blotting 
Hi5 cells were infected with the recombinant baculovirus expressing the Mediator 
Head module with eMOIs = 4.0 after Met depletion. 24 hours after addition of the virus, 
SeMet was added to the culture at a final concentration of 160 mg/L, and incubated for 
an additional 3 days. 1 ml aliquot of cell culture was taken every 24 hours, and cells 
were harvested in 1.5 ml tubes. Cell pellets were frozen in liquid nitrogen, and stored at 
-80°C until use. Preparation of cell lysate and the method for western blotting is 
described.21 The blot was probed for the Head module with anti–His tag monoclonal 
mouse antibody (Thermo Scientific Pierce) for 10xHis-tagged Med17, as well as with 
rabbit anti-Med18 (anti-Srb5) and rabbit anti-Med11 antibodies.37 Detection was carried 
out with a ChemiDoc MP imaging system (BioRad) using Dylight 680 goat anti–rabbit 
IgG (Thermo Scientific Pierce) for Med18 and Med11, and Dylight 800 goat anti-mouse 
IgG (Thermo Scientific Pierce) for anti-His tag as secondary antibodies.  
 
Supplemental Material 
Calculation of the SeMet incorporation rate using AAA data, and supplemental protocol 
for the SeM-TEQC method 
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Figure Legends
Figure 1: Effect of methionine depletion on Sf9 and Hi5 insect cells.  Hi5 and Sf9 
cells were grown in either Met-free or Met-containing medium as control. Cell viability 
(% of live cells) and cell density of each culture was measured every 24 hours for a total 
of 4 days. (A) Cell viability of Sf9 cells with or without Met. (B) Cell density of Sf9 cells 
with or without Met. (C) Cell viability of Hi5 cells with or without Met. (D) Cell density of 
Hi5 cells with or without Met. Measurements were performed in triplicates and 
averaged. Cyan: Met-containing medium; green: Met-free medium
Figure 2: Effect of SeMet on Sf9 or Hi5 insect cells cultured in Met-containing 
medium, or Met-free medium.  Hi5 or SF9 cells were seeded in Met-containing or Met-
free medium followed by addition of SeMet to the final concentration of 0 (control), 20, 
40, 80, 120, 160, and 200 mg/L, respectively. Cell viability (% of live cells) and cell 
density of each culture was measured every 24 hours for a 4-day span. (A) Cell viability 
of Sf9 cells in Met-containing medium. (B) Cell growth of Sf9 cells in a Met-containing 
medium. (C) Cell viability of Sf9 cells in Met-free medium. (D) Cell growth of Sf9 cells in 
Met-free medium. (E) Cell viability of Hi5 cells in a Met-containing medium. (F) Cell 
growth of Hi5 cells in a Met-containing medium. (G) Cell viability of Hi5 cells in Met-free 
medium (H) Cell growth of Hi5 cells in Met-free medium. Final concentration of SeMet: 
green: 0 mg/L; yellow: 20 mg/L; red: 40 mg/L; magenta: 80 mg/L; gray: 120 mg/L; blue: 
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Figure 3: Effect of baculovirus infection on SeMet toxicity.  (A) Overall experimental 
scheme. On Day 0, culture medium was exchanged from Met-containing to Met-free to 
deplete intracellular methionine. On Day 1, the baculovirus expressing the Mediator 
Head module with an eMOI=3.7 was added to the culture. On Day 2, SeMet was added 
to each culture to the final concentration of 0 (control), 20, 40, 80, 120, 160, and 200 
mg/L, respectively. As for the control, native expression was set up such that Met with a 
final concentration of 100 mg/L was added. Cell viability (% of live cells) (B), and cell 
density (C) of each culture was measured every 24 hours for a 4-day period (Day 1-5). 
Cyan: 100 mg/L of Met, for SeMet, green: 0 mg/L; yellow: 20 mg/L; red: 40 mg/L; 
magenta: 80 mg/L; gray: 120 mg/L; blue: 160 mg/L; dark green: 200 mg/L.
Figure 4: Cell viability and recovery of the SeMet-labeled Mediator Head module 
in the presence of SeMet depends on infectivity (or MOI).  (A)-(B) Cell viability as a 
function of estimated multiplicity of infection (eMOI), or initial infectivity. Following the 
experimental scheme described in Figure 3(A), after Met depletion process, the 
recombinant baculovirus expressing the Mediator Head module at eMOI ranging from 
0.25 (cyan), 0.5 (green), 1.0 (yellow), 2.0 (red) and 4.0 (purple) was added on Day 1 
followed by addition of Met at a final concentration of 100 mg/L as native expression 
control, or SeMet at a final concentration of 160 mg/L on Day 2. Cell viability at each 
condition was monitored during a 4-day period (Day 1-5), and cell viability (%) at each 
condition was plotted. (A) Native expression. (B) SeMet labeling expression. (C) 
Comparison of cell viability between native vs. SeMet containing expressions at Day 5 
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Recovery of the Mediator Head module in native or SeMet labeling expression condition 
as a function of estimated multiplicity of infection (eMOI), or initial infectivity. Cells were 
harvested on Day 5. The Mediator Head module was affinity-purified and quantified. 
The complex yield from each culture was measured and the data were plotted as a 
function of eMOI or initial infectivity. Yield was displayed as amount of the protein 
complex (mg) obtained from 1 L culture. Initial infectivities (%) correspond to eMOI were 
displayed below eMOI values. Cyan box: Native expression, green box: SeMet labeling 
expression. (E) SDS-PAGE of the Mediator Head module obtained from the native 
expression on the left and SeMet-labeling expression on the right. (*): Contaminant from 
the insect cells
Figure 5: Effect of SeMet concentration on SeMet incorporation rate as well as on 
recombinant Mediator Head module recovery.  Following the experimental scheme 
described in Figure 3(A), Hi5 or Sf 9 cells (200 ml in 1-L shake flask) underwent the Met 
depletion process followed by the addition of the recombinant baculovirus expressing 
the Mediator Head module at eMOI of 4.0 on Day 1. On Day 2, SeMet was added to 
various final concentrations ranging from 20, 40, 80, 120, 160, and 200 mg/L, 
respectively. As for the control, a native expression was set up such that Met with a final 
concentration of 100 mg/L was added on Day 2. Cells were harvested on Day 5. The 
recombinant Mediator Head module was affinity-purified21 and the protein complex yield 
at each condition was quantified. Plot of SeMet incorporation rate (%) into recombinant 
Mediator Head module expressed in Hi5 cells (A) or Sf9 cells (C) as a function of the 
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Mediator Head module expressed in Hi5 cells (B) or Sf9 cells (D) at each SeMet (or 
Met) concentration condition was plotted. Native: native expression where Met was 
added to a final concentration of 100 mg/L on Day 2; final concentrations of SeMet 
added on Day 2 is indicated in the plot. 
Figure 6: Application of the SeMet labeling method to human Taf8-Taf10, yeast 
Mediator Middle module, and yeast TFIIF complexes involved in RNA polymerase 
II transcription.  SeMet-labeling method, “SeM-TEQC”, used for the Mediator Head 
module was applied to human Taf8-Taf10, the yeast Mediator Middle module, and yeast 
TFIIF. Human Taf8-Taf10, and the yeast Mediator Middle module were expressed in 
Hi5 cells, and yeast TFIIF was expressed in Sf9 cells. Following the experimental 
scheme described in Figure 3(A), Hi5 or Sf9 cells (200 ml in 1-L shake flask) underwent 
Met depletion process. On Day 1, the recombinant baculovirus expressing human Taf8-
Taf10, the yeast Mediator Middle module, or yeast TFIIF at an eMOI ranging from 0.5, 
1.0, 2.0 and 4.0 was added followed by addition of Met at a final concentration of 100 
mg/L as native expression control, or SeMet at a final concentration of 160 mg/L for Hi5 
cells and 200 mg/L for Sf9 cells on Day 2. Cells were harvested on Day 5. For each 
condition, the three protein complexes were purified, the protein complex yields, as well 
as SeMet incorporation rates (%) were measured. Plot of SeMet incorporation rate (%) 
as a function of eMOI is displayed on the left; protein complex yields in native or SeMet-
labeling expression as a function of eMOI is displayed in the middle; and SDS-PAGE of 
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right. Lanes 1-4: eMOI=0.5, 1.0, 2.0, 4.0; Lanes 5-8: eMOI=0.5, 1.0, 2.0, 4.0. (A) Human 
Taf8-Taf10, (B) yeast Mediator Middle module, and (C) yeast TFIIF.
Figure 7: Expression profile of the Mediator Head Module during SeMet-labeling 
Mediator Head Module production over the course of a standard SeMet labeling 
procedure [Fig. 3(A)] compared to native expression was monitored by Western Blot 
analysis. Hi5 cells were grown in a Met-free medium for 24 hours, followed by virus 
infection (Day 1). After a 24-hour incubation period, either Met or SeMet was added to a 
final concentration of 100 mg/L or 160 mg/L, respectively, and the cells cultured for 
another 72 hours. Cell samples were collected every 24 hours (Day 1 to Day 5), lysed 
and subjected for SDS-PAGE followed by Western blotting. Western Blot of three 
representative subunits, Med17, Med18 and Med11, of the Mediator Head Module 
probed with either anti-His (Med17), anti-Med18 and anti-Med11, respectively. Time 
points of virus as well as Met or SeMet addition are indicated by arrows. Molecular 
mass (kDa) of each subunit is indicated on the left.  (*) Signal bleed-over from adjacent 
marker lane.
Figure 8: Comparison between Se anomalous peaks on the Med18-Med20 
structure, and the known positions of methionine residues in the Med18-Med20 
structure.  Se Anomalous Difference Fourier Map was superimposed onto the cartoon 
view of the high-resolution structure of the Med18-Med20 structure determined in the 
previous study.38 The Selenium anomalous difference Fourier map calculated from 20-6 
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in the asymmetric unit are displayed individually as (A)-(C). The height of the 
anomalous peaks is shown in Table 2. M: methionine residue (e.g. M57: methionine 
residue 57).
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Table 1. Peaks in 20-6 Å Anomalous
Difference Fourier Map
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Table 2. Se Anomalous Difference Fourier Map Peak Hight of Med18
Met residue Number Mol1 Mol2 Mol3
1 ND ND ND
80 ND 7.0 ND
81 3.8 4.4 6.0
104 ND ND ND
150 ND ND ND
182 6.3 7.2 5.9
204 6.6 8.7 ND
224 6.6 8.7 6.9
276 4.9 4.7 3.9
296 ND 4.5 3.0
 Se Anomalous Difference Fourier Map Peak Hight of Med20
Met residue Number Mol1 Mol2 Mol3
1 ND ND ND
57 ND 9.6 6.1
78 ND 6.8 ND
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